abstract |
The present invention relates to novel sulfone-substituted 2,3-dihydroimidazo [1,2-c] quinazoline compounds, pharmaceutical compositions containing such compounds, and phosphotidylinositol-3-kinase (PI3K) inhibition, and As a single agent or in combination with other active ingredients for the treatment of diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular the treatment of hyperproliferative and / or angiogenesis-mediated diseases All of these compounds or compositions. |